Tailoring Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Recent Advances and Strategies.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38471052.
- Also identified by DOI 10.1200/OP.23.00563 and PMC identifier 11368165.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Neoadjuvant HER2 Therapy: Beyond one-size-fits-all.
Medical subject headings
- Neoadjuvant Therapy
- Breast Neoplasms
- Erb-b2 Receptor Tyrosine Kinases